Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Sclerodermatous Graft Versus Host Disease”

2 trials

Showing 2 of 2 results

Testing effectiveness (Phase 2)Ended earlyNCT02337517
What this trial is testing

Vismodegib in Treating Patients With Steroid-Refractory Chronic Graft-Versus-Host Disease

Who this might be right for
Chronic Graft Versus Host Disease
National Cancer Institute (NCI) 6
Very early researchWithdrawnNCT05515692
What this trial is testing

Electron Beam Radiotherapy for the Treatment of Refractory Sclerodermatous Chronic Graft Versus Host Disease

Who this might be right for
Hematopoietic and Lymphoid System NeoplasmMalignant Solid NeoplasmRefractory Sclerodermatous Graft Versus Host Disease
City of Hope Medical Center

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation